Learn more

S BIO PTE LTD

Overview
  • Total Patents
    97
About

S BIO PTE LTD has a total of 97 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), Argentina and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are BUSCH-PETERSEN JAKOB, YM BIOSCIENCES AUSTRALIA PTY and ACTELION PHARMACEUTICALS LTD.

Patent filings per year

Chart showing S BIO PTE LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sun Eric T 41
#2 Nagaraj Harish Kumar Mysore 27
#3 Chen Dizhong 25
#4 William Anthony Deodaunia 21
#5 Lee Cheng Hsia Angeline 21
#6 Williams Meredith 18
#7 Poulsen Anders 17
#8 Wang Haishan 17
#9 Blanchard Stephanie 15
#10 Lee Ken Chi Lik 13

Latest patents

Publication Filing date Title
WO2011078795A1 Bridged morpholino substituted purines
WO2011008172A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
WO2010114494A1 8-substituted-2-morpholino purines for use as pi3k and/or mtor inhibitors in the treatment of proliferative disorders
WO2010068182A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
MX2011006206A 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyc lo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16 ,21,23-decaene citrate salt.
EP2310391A1 Pyrazine substituted purines
BRPI0925059A2 Substituted pyrimidine of purine compounds as inhibitor kinase (s).
WO2009093981A1 Triazine compounds as kinase inhibitors
WO2009045174A1 2-morpholinylpurines as inhibitors of pi3k
WO2008140421A2 Heterocycloalkyl substituted pyrimidine derivatives
WO2008140420A2 Pyrimidine derivatives
WO2008140419A2 Pyridyl substituted pyrimidine derivatives
US2010098691A1 Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
WO2008060248A1 Indole sustituted pyrimidines and use thereof in the treatment of cancer
US2008085896A1 Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
EP1951730A1 Heteroalkyl linked pyrimidine derivatives
WO2007058626A1 Indazole compounds
ZA200804208B Oxygen linked pyrimidine derivatives
WO2007053114A1 Method of predicting a response to hdac inhibitors
AU2006220413A1 Compounds